Benefits Of 5KL Bioreactor When Outsourcing Late-Phase Biologics Drug Substance Manufacturing
Source: Thermo Fisher Scientific
When you look at the current challenges in upstream bioprocessing, two come to the forefront as critical. The first is intensified cell culture processes which present a challenge for the bioreactor space—specifically for improving the mixing and mass transfer of performance. The second is a demand for flexible and efficient manufacturing which is driven by a shift in volumetric demand profiles.
Watch this webinar today and discover how Thermo Fisher Scientific is addressing and overcoming these two challenges of bioprocessing.
VIEW THE WEBINAR!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Outsourced Pharma? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more